235980.KQ
MedPacto, Inc.
KOE · Healthcare · Biotechnology · KR
KRW 2,795.00
−0.89%Year over year
Reported trailing growth
- Revenue
- +293.4%
- EBITDA
- -60.5%
- EBIT
- -15.4%
- EPS
- -18.0%
- Free cash flow
- -10.9%
- Operating cash flow
- -14.0%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- —
- EBITDA
- +28.6%
- EBIT
- +35.7%
- Net income
- +36.4%
- EPS
- +37.5%
- Free cash flow
- +20.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026